Botulinum toxin in the treatment of Raynaud's phenomenon: A pilot study [1]

European Journal of Clinical Investigation

Volumn 34, Issue 4, 2004, Pages 312-313

  Sycha, T ^a,b   Graninger, M ^a   Auff, E ^a   Schnider, P ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ANALGESIA; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; RANDOMIZATION; RAYNAUD PHENOMENON;

ADULT; AGED; BOTULINUM TOXIN TYPE A; FEMALE; HUMANS; NEUROMUSCULAR AGENTS; PILOT PROJECTS; RAYNAUD DISEASE; SKIN; TREATMENT OUTCOME;

EID: 2142704322     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2004.01324.x     Document Type: Letter

References (7)

1. Freedman RR, Janni P. Role of cold and emotional stress in Raynaud's disease and scleroderma. BMJ 1983;287:1499-502.
2. Tindall JP, Whalen RE, Burton EE Jr. Medical uses of intra-arterial injections of reserpine: treatment of Raynaud's syndrome and of some vascular insufficiencies of the lower extremities. Arch Dermatol 1974;110:233-7.
3. Blunt RJ, Porter JM. Raynaud syndrome. Semin Arthritis Rheum 1981;10:282-308.
4. Schnider P, Binder M, Auff E, Kittler H, Berger T, Wolff K. Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. Br J Dermatol 1997;136:548-52.
5. Morris JL, Jobling P, Gibbins IL. Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons. Am J Physiol Heart Circ Physiol 2001;281:H2124-H2132.
6. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. BMJ 2001;232:596-9.
7. Heckmann M, Ceballos-Baumann AO, Plewig G. Botulinum toxin A for axillary hyperhidrosis. N Engl J Med 2001;344:488-93.